Jan Haas

Angel investor in Boston

Invests in AI

Jan Haas's investor profile lists AI alongside Healthcare & Biotech, Digital Health & HealthTech and Biotech & Pharma, at early-stage venture. The record holds 2 deals, among them Comdisco Ventures and NXT Capital.

Email Investor

Email Investor

Credits to line up before an early-stage round

Jan Haas backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Comdisco Ventures
  • NXT Capital

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma, MedTech & Medical Devices, SaaS & Enterprise and 7 more
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
2
Based in
Boston, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Jan Haas invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Jan Haas's investor profile, together with Healthcare & Biotech, Digital Health & HealthTech and Biotech & Pharma. The stages on record are early-stage venture.
Which companies has Jan Haas backed?
The record lists 2 deals, including Comdisco Ventures and NXT Capital. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Jan Haas?
For a company raising an early-stage round, AI Perks lists credits such as Beefree SDK (up to $10,000), Confluent (up to $20,000), Vertex AI (up to $350,000) and Retool (up to $225,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor